Resmed Inc(RMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 4:00 PM ET (Korea 9/11 05:00)
Full metrics table
| Index | S&P 500 | P/E | 21.04 | EPS (ttm) | 10.44 | Insider Own | 0.95% | Shs Outstand | 144.2M | Perf Week | -4.89% |
| Market Cap | 31.67B | Forward P/E | 16.51 | EPS next Y | 9.97% | Insider Trans | -3.31% | Shs Float | 142.9M | Perf Month | -2.34% |
| Enterprise Value | 31.03B | PEG | 1.81 | EPS next Q | 2.69 | Inst Own | 72.77% | Short Float | 8.95% | Perf Quarter | 13.44% |
| Income | 1.52B | P/S | 5.6 | EPS this Y | 8.28% | Inst Trans | 0.81% | Short Ratio | 8.57 | Perf Half Y | -8.57% |
| Sales | 5.65B | P/B | 4.81 | EPS next 5Y | 9.12% | ROA | 17.77% | Short Interest | 12.79M | Perf YTD | -8.84% |
| Book/sh | 45.66 | P/C | 21.51 | EPS past 3/5Y | 19.66% 26.34% | ROE | 24.27% | 52W High | -22.92% ($284.87) | Perf Year | -18.82% |
| Cash/sh | 10.21 | P/FCF | 19.2 | Sales past 3/5Y | 10.21% 12.08% | ROIC | 21.39% | 52W Low | 21.81% ($180.26) | Perf 3Y | 48.42% |
| Dividend Est. | $2.65 (1.21%) | EV/EBITDA | 14.32 | EPS Y/Y TTM | 9.65% | Gross Margin | 60.25% | Volatility(W/M) | 2.28% 2.71% | Perf 5Y | -25.71% |
| Dividend TTM | 2.46 | EV/Sales | 5.49 | Sales Y/Y TTM | 9.85% | Oper. Margin | 34.01% | ATR (14) | 6.47 | Perf 10Y | 235.49% |
| Dividend Ex-Date | 2026/8/20 | Quick Ratio | 2.42 | EPS Q/Q | 2.42% | Profit Margin | 26.94% | RSI (14) | 43.68 | Recom | 2.13 |
| Dividend Gr. 3/5Y | 10.89% 9% | Current Ratio | 3.1 | Sales Q/Q | 8.58% | SMA20 | -4.19% ($229.18) | Beta | 0.75 | Target Price | $262.07 |
| Payout | 23.01% | Debt/Eq | 0.13 | Earnings | 2026/8/6 | SMA50 | 1.37% ($216.61) | Rel Volume | 0.55 | Prev Close | $219.95 |
| Employees | 11370 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 1.98% 0.16% | SMA200 | -3.7% ($228.02) | Avg Volume(3M) | 1.49M | Price | $219.58 |
| IPO | 1995/6/2 | Option/Short | Yes/Yes | Trades | 14947 | Volume | 814,828 | Change | -0.17% |
Company
RMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global medical device company specializing in software-based digital health solutions for sleep apnea and respiratory diseases. Founded in 1989 in Sydney, Australia, the company is headquartered in California, USA, and serves as a key part of a global respiratory medical device group, supplying CPAP devices, masks, and respiratory equipment for sleep apnea (OSA) as well as chronic care software.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
RMD makes money exceptionally well
34.01% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.3% this year.
Tap to view numbers
The price looks about right
Trading at 21.0 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +48.4% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.21% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 72.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
LGHT 0.09%
EKG 0.06%
IHI 0.04%
HEAL 0.04%
CWS 0.03%It ranks #4 in the industry
Based on market cap of $32B.
RMD $32B PER 21.0
ISRG $127B PER 41.3
BDX $48B PER 53.2
MDLN $43B PER 38.0
FAQ
What kind of company is RMD?
RMD belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of RMD?
The market cap of RMD is approximately $31.7B, ranking 450 within its sector.
Does RMD pay dividends?
RMD has a dividend yield of approximately 1.21%, with an annual dividend of $2.65.
What is the P/E ratio of RMD?
RMD has a P/E ratio of approximately 21.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for RMD?
RMD has recorded a 52-week high of $284.87 and a low of $180.26.
